Medtronic has presented first results of the Resolute All Comers study at the clinical trial session of the 2010 EuroPCR meeting. In the 2,292-patient randomized trial, the Resolute zotarolimus-eluting stent from Medtronic was found to be as safe and effective as the Xience V everolimus-eluting stent from Abbott Laboratories.

See the original post here:
Medtronic Presents Resolute All Comers Study Results